[Significance of immunotherapy as an adjunct to surgical treatment in non-small cell carcinoma of the lung].
Active and adoptive immunotherapy as an adjunct to surgical treatment in non-small cell lung cancers was analysed, based on the results of our TF experiences and a literature review, and its significance was discussed.
Fujisawa
T
T
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D001500:BCG Vaccine / Q000627:therapeutic use; D018288:Carcinoma, Small Cell / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D003131:Combined Modality Therapy; D006801:Humans; D007978:Levamisole / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D010844:Picibanil / Q000627:therapeutic use; D011013:Pneumonectomy; D011182:Postoperative Care
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine; D007978:Levamisole; D010844:Picibanil